 |
|
Prediction models of hepatocellular carcinoma recurrence after liver transplantation: A comprehensive review
Sang Jin Kim, Jong Man Kim
Clin Mol Hepatol. 2022;28(4):739-753. Published online 2022 Apr 26 DOI: https://doi.org/10.3350/cmh.2022.0060
|
|
Citations to this article as recorded by
 Tenofovir versus entecavir on decreasing risk of HBV-related hepatocellular carcinoma recurrence after liver transplantation
Jianming Yang, Yewu Chen, Haobin Sun, Xijian Zhang, Jianfeng Wang, Zhixing Liang, Binsheng Fu, Tong Zhang, Shuhong Yi, Yinan Deng, Yang Yang
Infectious Agents and Cancer.2023;[Epub] CrossRef Molecular Clues for Prediction of Hepatocellular Carcinoma Recurrence after Liver Transplantation
Nourhan Badwei
Journal of Clinical and Experimental Hepatology.2023;[Epub] CrossRef Persistently Elevated HBV Viral-Host Junction DNA in Urine as a Biomarker for Hepatocellular Carcinoma Minimum Residual Disease and Recurrence: A Pilot Study
Selena Y. Lin, Dina Halegoua-DeMarzio, Peter Block, Yu-Lan Kao, Jesse Civan, Fwu-Shan Shieh, Wei Song, Hie-Won Hann, Ying-Hsiu Su
Diagnostics.2023; 13(9): 1537. CrossRef Neutrophil extracellular traps and complications of liver transplantation
Yanyao Liu, Ping Yan, Yue Bin, Xiaoyan Qin, Zhongjun Wu
Frontiers in Immunology.2022;[Epub] CrossRef
|